404
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone

, , , , , & show all
Pages 1956-1960 | Received 13 Jun 2015, Accepted 02 Nov 2015, Published online: 04 Jan 2016
 

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2015.1117610 (www.informahealthcare.com/lal). This research was supported by a grant from the National Research Foundation of Korea (NRF) (NRF-2013R1A1A2013210) funded by Ministry of Education, Science and Technology (MEST), and a grant for the Global Core Research Center (GCRC) (No. 2012-0001190) funded by Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.